PDL BioPharma (PDLI) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
CWD, VUZI, INSE, More
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
CWD, VUZI, INSE, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q4 EPS of $0.61, $0.07 better than the analyst estimate of $0.54. Revenue for the quarter came in at $178.1 million versus the consensus estimate of $149.2 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Charles Schwab (SCHW) EPS edges past estimates, revenue up sequentially but dips YoY
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- M&T Bank (MTB) shares climb as Q1 2024 earnings meet expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
